West Pharmaceutical Services Inc. buy UBS Group AG
Start price
25.07.25
/
50%
€226.50
Target price
25.07.26
€272.54
Performance (%)
-6.84%
Price
13.02.26
€211.00
Summary
This prediction is currently active. With a performance of -6.84%, the BUY prediction by UBS_Group_AG is trending in the wrong direction. This prediction currently runs until 25.07.26. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| West Pharmaceutical Services Inc. | 0.190% | 0.190% |
| iShares Core DAX® | 1,93 % | -2,11 % |
| iShares Nasdaq 100 | -0,18 % | -5,90 % |
| iShares Nikkei 225® | 7,08 % | 6,46 % |
| iShares S&P 500 | -0,20 % | -3,67 % |
Comments by UBS_Group_AG for this prediction
In the thread West Pharmaceutical Services Inc. diskutieren
West Pharmaceutical Services, Inc. (NYSE: WST) had its price target raised by analysts at UBS Group AG from $285.00 to $320.00. They now have a "buy" rating on the stock.
Ratings data for WST provided by MarketBeat
Stopped prediction by UBS_Group_AG for West Pharmaceutical Services Inc.
West Pharmaceutical Services Inc.
Start price
Target price
Perf. (%)
€208.70
13.02.26
13.02.26
-
13.02.27
13.02.27
1.10%
13.02.26
13.02.26
West Pharmaceutical Services Inc.
Start price
Target price
Perf. (%)
€310.00
12.12.24
12.12.24
€372.22
12.12.25
12.12.25
-27.03%
13.12.25
13.12.25